ÂÜÀòÂÒÂ×

Gary Bohnert is a skilled medicinal chemist with extensive experience in drug discovery and development, currently serving as a Medicinal Chemist at PostEra since July 2023. Previously, Bohnert co-founded Cognesy Therapeutics and held the position of Senior Director of Chemistry from September 2021 to August 2023. Prior roles include Principal Scientist at EMD Serono, Inc. and Investigator at GSK, where Bohnert led chemistry efforts in immuno-inflammation and immuno-oncology programs. Bohnert's earlier career includes significant contributions as a Senior Scientist at Tempero Pharmaceuticals and Synta Pharmaceuticals, focusing on key therapeutic areas and progressing compounds to pre-clinical candidates. Bohnert's academic background includes a Ph.D. in Synthetic Organic Chemistry from the University of Missouri-Columbia and a Bachelor of Science in Chemistry from Southeast Missouri State University.